2 hours EyePoint Pharmaceuticals (NASDAQ:EYPT) Now Covered by ScotiabankMarketBeat
Scotiabank began coverage on EyePoint Pharmaceuticals in a research report on Wednesday. They set a “sector outperform” rating for the company.
Nasdaq 100 · Pharmaceuticals · Science · Scotiabank
X